Cure My Disease

Don't miss your cure!

 Log in / Sign up

New biologic drug tested to tame severe childhood eczema

NCT ID NCT04678882

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study tested an injectable drug called dupilumab, given with a standard steroid cream, in 62 Japanese children and teenagers (aged 6 months to 18 years) with moderate-to-severe eczema that wasn't well-controlled by their usual treatments. The main goal was to see if the drug combination was better than a placebo (dummy injection) at reducing the severity and itch of eczema over 16 weeks. Researchers also closely monitored the drug's safety and how the body processed it in this young age group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 3920001

    Hiroshima, Hiroshima, 734-8551, Japan

  • Investigational Site Number : 3920003

    Sagamihara-shi, Kanagawa, 252-0392, Japan

  • Investigational Site Number : 3920006

    Tsu, Mie-ken, 514-0125, Japan

  • Investigational Site Number : 3920007

    Kobe, Hyōgo, 658-0082, Japan

  • Investigational Site Number : 3920008

    Kobe, Hyōgo, 653-0836, Japan

  • Investigational Site Number : 3920009

    Sapporo, Hokkaido, 060-0807, Japan

  • Investigational Site Number : 3920010

    Yokohama, Kanagawa, 225-0015, Japan

  • Investigational Site Number : 3920011

    Nagoya, Aichi-ken, 457-8510, Japan

  • Investigational Site Number : 3920012

    Koto-ku, Tokyo, 136-0074, Japan

  • Investigational Site Number : 3920013

    Sapporo, Hokkaido, 004-0063, Japan

  • Investigational Site Number : 3920014

    Toyoake-shi, Aichi-ken, 470-1192, Japan

  • Investigational Site Number : 3920015

    Fukutsu-shi, Fukuoka, 811-3217, Japan

  • Investigational Site Number : 3920016

    Kumagaya-shi, Saitama, 360-0018, Japan

  • Investigational Site Number : 3920017

    Yokohama, Kanagawa, 221-0825, Japan

  • Investigational Site Number : 3920019

    Toyonaka-shi, Osaka, 560-0085, Japan

  • Investigational Site Number : 3920020

    Sakai-shi, Osaka, 593-8324, Japan

  • Investigational Site Number : 3920021

    Habikino-shi, 583-8588, Japan

  • Investigational Site Number : 3920022

    Toshima-ku, Tokyo, 170-0002, Japan

  • Investigational Site Number : 3920023

    Chuo-ku, Tokyo, 104-0031, Japan

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS